Methotrexate-Loaded Surface-Modified Solid Lipid Nanoparticles Targeting Cancer Expressing COX-2 Enzyme
Langmuir · 2024
DOI: 10.1021/acs.langmuir.4c00638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Langmuir, 2024. Verfasst von Swagata Patra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur 721302, India. Hauptthemen laut MEDLINE: Methotrexate, Cyclooxygenase 2, Nanoparticles. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Indian Institute of Technology Kharagpur, Ministry of Education, India.
Abstract (Originalsprache)
Cancer is a major public health problem worldwide, and it is the second leading cause of death of humans in the world. The present study has been directed toward the preparation of methotrexate-loaded surface-modified solid lipid nanoparticles (SLNs) for potential use as a chemotherapeutic formulation for cancer therapy. A lipid (C14-AAP) derived from myristic acid (C14H30O2) and acetaminophen (AAP) was employed as a targeting ligand for human breast and lung cancer cells that overexpress the cyclooxygenases-2 (COX-2) enzyme. The SLNs consisting of stearic acid and C14-AAP were characterized by several methods, including dynamic light scattering (DLS), differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), ultraviolet-visible (UV-vis) spectroscopy, high-resolution transmission electron microscopy (HRTEM), and field emission scanning electron microscopy (FESEM) techniques. An in vitro cell cytotoxicity study was done by carrying out an MTT assay and flow cytometry study in the human breast cancer (MCF7) and human lung cancer cell line (A549). The expression level of COX-2 enzyme in MCF7 and A549 cell lines was examined by reverse transcription polymerase chain reaction (RT-PCR). A high level of COX-2 expression was observed in both cell lines. In vitro cell cytotoxicity study in MC7 and A549 cell lines showed the surface-modified, methotrexate-loaded SLN is more effective in cell killing and induction of apoptotic death in both the cell lines than free methotrexate in MTT, flow cytometry, clonogenic assay, and Western blot studies. The surface-modified SLN was radiolabeled with 99mTc with %RCP greater than 95%. In vivo biodistribution study of the 99mTc-labeled SLN in melanoma tumor-bearing C57BL6 mice showed moderate tumor uptake of the radiotracer at 3 h post injection. The SPECT/CT image aligns with the biodistribution results. This study shows that AAP-modified SLNs could be a potential chemotherapeutic formulation for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
- Radiation Medicine Centre, Bhabha Atomic Research Centre, Parel, Mumbai 400012, India.
ORCID-Profile: Joykrishna Dey
Förderung
- Indian Institute of Technology Kharagpur
- Ministry of Education, India
Zitieren
APA
Patra, S., Dey, J., Kar, S., Chakraborty, A., & Tawate, M. (2024). Methotrexate-Loaded Surface-Modified Solid Lipid Nanoparticles Targeting Cancer Expressing COX-2 Enzyme. Langmuir. https://doi.org/10.1021/acs.langmuir.4c00638
Vancouver
Patra S, Dey J, Kar S, Chakraborty A, Tawate M. Methotrexate-Loaded Surface-Modified Solid Lipid Nanoparticles Targeting Cancer Expressing COX-2 Enzyme. Langmuir. 2024. doi:10.1021/acs.langmuir.4c00638
BibTeX
@article{Patra2024,
author = {Patra, Swagata and Dey, Joykrishna and Kar, Somnath and Chakraborty, Avik and Tawate, Megha},
title = {Methotrexate-Loaded Surface-Modified Solid Lipid Nanoparticles Targeting Cancer Expressing COX-2 Enzyme},
journal = {Langmuir},
year = {2024},
doi = {10.1021/acs.langmuir.4c00638}
}
EUVIMED